dr. rugo discusses monarch i in hr her2- breast cancer
Published 7 years ago • 116 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:11
dr. rugo on the significance of the monarch i trial for breast cancer
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
1:05
dr. rugo on ongoing trials in her2 breast cancer
-
1:22
dr. rugo discusses late recurrence in hr breast cancer
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer
-
0:52
dr. rugo discusses guidelines for metastatic breast cancer management
-
2:07
dr. rugo on the advances in the treatment of her2-positive breast cancer
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
1:42
dr. rugo on chemotherapy for metastatic breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:36
dr. rugo on the efficacy of bevacizumab in breast cancer
-
2:02
dr. dickler on monarch 1 results in hr /her2- breast cancer
-
5:06
monarch 1: abemaciclib monotherapy for hr mbc
-
1:52
dr. rugo on swish trial for hr-positive breast cancer
-
6:06
immunotherapy in breast cancer
-
1:15
dr. rugo on unmet needs beyond second-line treatment in her2 breast cancer
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
1:23
dr. rugo on pathway changes in breast cancer